In our latest episode, we’re tackling the thorny issue of therapeutic cancer vaccines. Nothwithstanding some recent clinical trial failures, there’s still considerable interest in this topic.
Are we on the threshold of a renaissance — a rebirth or awakening in the way we can stimulate the immune system to attract more cytolytic T cells into the tumour? If not, what needs to be done for this to happen? If so, what would the new approach(es) look like and how would they differ from what’s gone before?